🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ADDR 50 days' free access: 3D printing in musculoskeletal interface engineering: current progress and future directions. By Xin Zhao & coworkers The Hong Kong Polytechnic University (PolyU) #3Dprinting kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Acoustic Tweezers For Targeted Drug Delivery. By Michael Baudoin & coworkers Université Polytechnique Hauts-de-France CRS BeNeLux & France Local Chapter #TargetedDelivery # kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Targeting Tumor-Associated Microbiome: A New Aspect of Modulating Tumor Microenvironment for Cancer Therapy. By Leaf Huang & coworker Pharmacoengineering & Mol Pharmaceutics (DPMP UNC) #microbiome #TumorMicroenvironment kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Optical coherence tomography for noninvasive monitoring of drug delivery. By Kirill V. Larin & coworker University of Houston #tomography #intravitreal #subretinal kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Modulating the Electronic Structure of Graphdiyne-Based Nanomaterials for Engineering Nano-Bio Interfaces in Biomedical Applications. By Chunying Chen, Chinese Academy of Medical Sciences #graphdiyne #ElectronicStructure kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Nanoparticles Targeting the Central Circadian Clock: Potential Applications for Neurological Disorders. By Valle Palomo IMDEA Institutes CRS Spanish Portuguese Local Chapter #CircadianClock #NeurologicalDisorder kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Intranasal NAP (Davunetide): Neuroprotection and Circadian Rhythmicity. By Illana Gozes Tel Aviv University #BrainDelivery #intranasal #tauopathy #CircadianClock kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Intranasal and Inhaled Delivery Systems for Targeting Circadian Dysfunction in Neurodegenerative Disorders, Perspective and Future Outlook. By Daniela Traini & coworkers Macquarie University Drug Delivery Australia #intranasal #inhalation kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Devices to Overcome the Buccal Mucosal Barrier to Administer Therapeutic Peptides. By David J. Brayden & coworkers UCD School of Veterinary Medicine UKICRS #PeptideDelivery #buccal #mucosal #device kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Be a GEM: biocontained, environmentally applied, genetically engineered microbes. By Tae Seok Moon J. Craig Venter Institute #probiotic #GeneticallyEngineeredMicrobe #regulation kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: hPSC-based Treatment of Retinal Diseases – current progress and challenges. By Michiko Mandai & coworkers, Kobe City Eye Hospital #PhotoreceptorCell #StemCell #transplantation #RetinalDisease kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Implantable systems for chronotherapy. By Giovanni Traverso & coworkers MIT MechE #BrainDelivery #chronotherapy kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Nanodiamond-Based Sensing: A Revolution for Biosensors in Capturing Elusive Bio-signals in Living Cells. By Heemin Kang & coworkers, Korea Univ. CRS Korea Chapter #nanodiamond #biosensor kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Designing Live Bacterial Therapeutics for Cancer. By Mark Mimee & coworkers UChicago Department of Microbiology #EngineeredBacteria #SyntheticBiology kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology. By Simone Schuerle & coworkers ETH Zürich #microrobot #SyntheticBiology kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Human Pluripotent Stem Cell-based Cardiac Repair: Lessons Learned and Challenges Ahead. By Michael A. Laflamme & coworkers McEwen Stem Cell Institute #StemCell #CardiacRepair kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Size-dependent penetration depth of colloidal nanoparticles into cell spheroids. By Wolfgang J. Parak & coworkers, Univ. of Hamburg Controlled Release Society - GerChAt Chapter #GoldNanoparticle #size #spheroid #penetration kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ow.ly/qIKw50VTkKY

ADDR Open Access: Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities. By Morten Otto Alexander Sommer & coworkers DTU #OralDelivery #absorption #microbiome kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Advances in Photoactivated Carbon-based Nanostructured Materials for Targeted Cancer Therapy. By Hossein Heidari & coworkers UCL UKICRS #graphene #nanosheet #phototherapy #photoacoustic kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…